Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Movement Disorders Associated with the Use of Gabapentin

Movement Disorders Associated with the Use of Gabapentin Summary: Purpose: We report two cases of unusual movement disorders associated with the use of gabapentin (GBP) in patients being treated for epilepsy who were otherwise neuro‐logically intact. Methods: We describe two cases of unusual movement disorders associated with the use of GBP. Results: There were significant differences in the clinical findings between the two cases. In the first case, movements were very pronounced and the patient was in oculogyric crisis. Movements in the second case were quite subtle but nonetheless problematic for the patient. In each case, discontinuation of GBP led to rapid resolution of the movements, although a single dose of lorazepam was used in the first case. Conclusions: Although formal electrophysiologic studies have not been performed, the movements associated with GBP use appear to be dystonic or myoclonic. Discontinuation of GBP led to rapid resolution of the movements. In severe cases, as in patients with oculogyric crisis, small doses of a benzodi‐azepine (BZD) appear to be efficacious and safe. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Epilepsia Wiley

Movement Disorders Associated with the Use of Gabapentin

Download PDF
3 pages

Loading next page...
 
/lp/wiley/movement-disorders-associated-with-the-use-of-gabapentin-BV21WgGpVA

References (21)

Publisher
Wiley
Copyright
Copyright © 1996 Wiley Subscription Services, Inc., A Wiley Company
ISSN
0013-9580
eISSN
1528-1167
DOI
10.1111/j.1528-1157.1996.tb00537.x
Publisher site
See Article on Publisher Site

Abstract

Summary: Purpose: We report two cases of unusual movement disorders associated with the use of gabapentin (GBP) in patients being treated for epilepsy who were otherwise neuro‐logically intact. Methods: We describe two cases of unusual movement disorders associated with the use of GBP. Results: There were significant differences in the clinical findings between the two cases. In the first case, movements were very pronounced and the patient was in oculogyric crisis. Movements in the second case were quite subtle but nonetheless problematic for the patient. In each case, discontinuation of GBP led to rapid resolution of the movements, although a single dose of lorazepam was used in the first case. Conclusions: Although formal electrophysiologic studies have not been performed, the movements associated with GBP use appear to be dystonic or myoclonic. Discontinuation of GBP led to rapid resolution of the movements. In severe cases, as in patients with oculogyric crisis, small doses of a benzodi‐azepine (BZD) appear to be efficacious and safe.

Journal

Epilepsia – Wiley

Published: Oct 1, 1996

There are no references for this article.